These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26580997)

  • 21. Activation Pathway of a Nucleoside Analog Inhibiting Respiratory Syncytial Virus Polymerase.
    Jordan PC; Stevens SK; Tam Y; Pemberton RP; Chaudhuri S; Stoycheva AD; Dyatkina N; Wang G; Symons JA; Deval J; Beigelman L
    ACS Chem Biol; 2017 Jan; 12(1):83-91. PubMed ID: 28103684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA interference therapy in lung transplant patients infected with respiratory syncytial virus.
    Zamora MR; Budev M; Rolfe M; Gottlieb J; Humar A; Devincenzo J; Vaishnaw A; Cehelsky J; Albert G; Nochur S; Gollob JA; Glanville AR
    Am J Respir Crit Care Med; 2011 Feb; 183(4):531-8. PubMed ID: 20851929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract.
    Marty FM; Chemaly RF; Mullane KM; Lee DG; Hirsch HH; Small CB; Bergeron A; Shoham S; Ljungman P; Waghmare A; Blanchard E; Kim YJ; McKevitt M; Porter DP; Jordan R; Guo Y; German P; Boeckh M; Watkins TR; Chien JW; Dadwal SS
    Clin Infect Dis; 2020 Dec; 71(11):2787-2795. PubMed ID: 31915807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM).
    Kelly G; Laxton C; Garelnabi M; Alton B; Addan F; Catchpole A; Thomas E; Borley D; Dee K; Boyers A; Bringas E; Noulin N; Lambkin-Williams R; Murray EJ
    J Virol Methods; 2015 Nov; 224():83-90. PubMed ID: 26335961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.
    Gane EJ; Roberts SK; Stedman CA; Angus PW; Ritchie B; Elston R; Ipe D; Morcos PN; Baher L; Najera I; Chu T; Lopatin U; Berrey MM; Bradford W; Laughlin M; Shulman NS; Smith PF
    Lancet; 2010 Oct; 376(9751):1467-75. PubMed ID: 20951424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion.
    Cho JY; Miller M; Baek KJ; Castaneda D; Nayar J; Roman M; Raz E; Broide DH
    J Allergy Clin Immunol; 2001 Nov; 108(5):697-702. PubMed ID: 11692091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice.
    Eichinger KM; Egaña L; Orend JG; Resetar E; Anderson KB; Patel R; Empey KM
    Respir Res; 2015 Oct; 16():122. PubMed ID: 26438053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome.
    Buckingham SC; Jafri HS; Bush AJ; Carubelli CM; Sheeran P; Hardy RD; Ottolini MG; Ramilo O; DeVincenzo JP
    J Infect Dis; 2002 May; 185(9):1222-8. PubMed ID: 12001038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
    Brookes DW; Coates M; Allen H; Daly L; Constant S; Huang S; Hows M; Davis A; Cass L; Ayrton J; Knowles I; Strong P; Rapeport G; Ito K
    Br J Pharmacol; 2018 Jun; 175(12):2520-2534. PubMed ID: 29579332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.
    Wronski S; Dannenmaier J; Schild S; Macke O; Müller L; Burmeister Y; Seilheimer B; Müller M
    PLoS One; 2018; 13(4):e0195822. PubMed ID: 29672626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.
    Oey A; McClure M; Symons JA; Chanda S; Fry J; Smith PF; Luciani K; Fayon M; Chokephaibulkit K; Uppala R; Bernatoniene J; Furuno K; Stanley T; Huntjens D; Witek J;
    PLoS One; 2023; 18(7):e0288271. PubMed ID: 37467213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pimodivir treatment in adult volunteers experimentally inoculated with live influenza virus: a Phase IIa, randomized, double-blind, placebo-controlled study.
    Trevejo JM; Asmal M; Vingerhoets J; Polo R; Robertson S; Jiang Y; Kieffer TL; Leopold L
    Antivir Ther; 2018; 23(4):335-344. PubMed ID: 29244026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
    Jordan R; Shao M; Mackman RL; Perron M; Cihlar T; Lewis SA; Eisenberg EJ; Carey A; Strickley RG; Chien JW; Anderson ML; McEligot HA; Behrens NE; Gershwin LJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4889-900. PubMed ID: 26055364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.
    Bisgaard H; Flores-Nunez A; Goh A; Azimi P; Halkas A; Malice MP; Marchal JL; Dass SB; Reiss TF; Knorr BA
    Am J Respir Crit Care Med; 2008 Oct; 178(8):854-60. PubMed ID: 18583576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection.
    van Woensel JB; Lutter R; Biezeveld M; Dekker T; Nijhuis M; van Aalderen WM; Kuijpers TW
    Pediatr Infect Dis J; 2003 Aug; 22(8):721-6. PubMed ID: 12913774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral load drives disease in humans experimentally infected with respiratory syncytial virus.
    DeVincenzo JP; Wilkinson T; Vaishnaw A; Cehelsky J; Meyers R; Nochur S; Harrison L; Meeking P; Mann A; Moane E; Oxford J; Pareek R; Moore R; Walsh E; Studholme R; Dorsett P; Alvarez R; Lambkin-Williams R
    Am J Respir Crit Care Med; 2010 Nov; 182(10):1305-14. PubMed ID: 20622030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azithromycin Treatment vs Placebo in Children With Respiratory Syncytial Virus-Induced Respiratory Failure: A Phase 2 Randomized Clinical Trial.
    Kong M; Zhang WW; Sewell K; Gorman G; Kuo HC; Aban I; Ambalavanan N; Whitley RJ
    JAMA Netw Open; 2020 Apr; 3(4):e203482. PubMed ID: 32324238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load.
    Devincenzo JP
    Pediatr Res; 2004 Dec; 56(6):914-7. PubMed ID: 15470202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.